ReviewInternational journal of nanomedicine2026
Cell Membrane-Coated Nanoparticles: Advanced Drug Delivery Systems for Chronic Wound Healing Therapy.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Advances in nano-TCM for Alzheimer's disease: lipid-based carriers integrated with innovative delivery strategies.Journal of nanobiotechnology · 2026Review
- Nature-Inspired Alternatives to PEG for Next-Generation Long-Circulating Nanocarriers.International journal of nanomedicine · 2026Review
- Application and Advances of Cell Membrane-Coated Nanoparticles in Diabetic Wound Healing.International journal of nanomedicine · 2026Review
- Key Tumor Responsive ZIF-8 Nanocarriers for Effective Anti-Cancer Therapeutics.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cell membrane-coated nanoparticles (CMNPs) have emerged as a promising platform for targeted drug delivery and therapeutic applications due to their unique properties, such as improved biocompatibility, prolonged circulation time, and ability to mimic natural cell functions. The preparation of CMNPs involves three critical stages: extraction of the cell membrane, preparation of the nanoparticle core, and membrane coating. The cell membrane is isolated through various methods, including hypotonic lysis, freeze-thaw cycles, and centrifugation, with careful attention paid to preserving its integrity and functionality. Nanoparticle cores, which can be organic (eg, PLGA, liposomes) or inorganic (eg, metal-based cores), offer distinct advantages in terms of drug loading capacity, stability, and therapeutic potential. The fusion of the core and the membrane is typically achieved through techniques such as membrane extrusion, sonication, and electroporation. These methods enable the efficient formation of core-shell nanostructures, which can be utilized for a range of biomedical applications, particularly in drug delivery, cancer therapy, and tissue regeneration. This review discusses the key aspects of CMNP preparation, including membrane extraction and purification techniques, core selection, and fusion methods, as well as the current trends and future directions in the development of CMNPs for therapeutic purposes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.